Follow
Derek van Tilborg
Derek van Tilborg
Verified email at tue.nl
Title
Cited by
Cited by
Year
Exposing the Limitations of Molecular Machine Learning with Activity Cliffs
D van Tilborg, A Alenicheva, F Grisoni
Journal of Chemical Information and Modeling 62 (23), 5938-5951, 2022
792022
Structure‐based Drug discovery with Deep Learning
R Özçelik, D van Tilborg, J Jiménez-Luna, F Grisoni
ChemBioChem, e202200776, 2023
202023
PANDORA: a fast, anchor-restrained modelling protocol for peptide: MHC complexes
DF Marzella, FM Parizi, D Tilborg, N Renaud, D Sybrandi, R Buzatu, ...
Frontiers in Immunology 13, 878762, 2022
18*2022
Cancers in Agreement? Exploring the Cross-Talk of Cancer Metabolomic and Transcriptomic Landscapes Using Publicly Available Data
D van Tilborg, E Saccenti
Cancers 13 (3), 393, 2021
32021
Deep learning for low-data drug discovery: hurdles and opportunities
D van Tilborg, H Brinkmann, E Criscuolo, L Rossen, R Özçelik, F Grisoni
22024
Traversing Chemical Space with Active Deep Learning
D van Tilborg, F Grisoni
22023
Machine learning-guided high throughput nanoparticle design
A Ortiz-Perez, D van Tilborg, R van der Meel, F Grisoni, L Albertazzi
22023
Traversing Chemical Space with Active Deep Learning: A Computational Framework for Low-data Drug Discovery
D van Tilborg, F Grisoni
2024
Computational models of synergy contribute to efficient combination screening
JCM Uitdehaag, MBW Prinsen, DW van Tilborg, JJ Kooijman, J Dylus, ...
Sigma 2, 0, 2019
2019
Combining cell panel profiling and synthetic lethality data to efficiently screen for synergistic combinations
JC Uitdehaag, DW Tilborg, MBW Prinsen, JJ Kooijman, J Dylus, ...
Cancer Research 79 (13_Supplement), 2158-2158, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–10